RCEL
Avita Medical, Inc. Common Stock
stockNASDAQ
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company's lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.67 | 2026-09-28 | +8.40% | 6.093 |
| 1M | 11.20 | 2026-09-04 | +12.95% | 2.557 |
| 3M | 5.19 | 2026-07-06 | +143.74% | 2.128 |
| 6M | 3.90 | 2026-04-06 | +224.36% | 1.542 |
| 1Y | 5.54 | 2025-10-03 | +128.34% | 1.530 |
| 2Y | 10.82 | 2024-10-04 | +16.91% | — |
| 5Y | 17.63 | 2021-10-04 | -28.25% | 1.428 |
Avita Medical, Inc. Common Stock (NASDAQ:RCEL) stock price today is $12.65, and today's volume is 391,214. RCEL is up 5.329% today. The 30 day average volume is 300,923. RCEL market cap is $391.22M with 30.93M shares outstanding.